MXPA01011286A - Derivados de ciclocarbamato como moduladores de receptor de progesterona. - Google Patents

Derivados de ciclocarbamato como moduladores de receptor de progesterona.

Info

Publication number
MXPA01011286A
MXPA01011286A MXPA01011286A MXPA01011286A MXPA01011286A MX PA01011286 A MXPA01011286 A MX PA01011286A MX PA01011286 A MXPA01011286 A MX PA01011286A MX PA01011286 A MXPA01011286 A MX PA01011286A MX PA01011286 A MXPA01011286 A MX PA01011286A
Authority
MX
Mexico
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
MXPA01011286A
Other languages
English (en)
Spanish (es)
Inventor
P Edwards James
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of MXPA01011286A publication Critical patent/MXPA01011286A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA01011286A 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona. MXPA01011286A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
MXPA01011286A true MXPA01011286A (es) 2003-07-14

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011286A MXPA01011286A (es) 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona.

Country Status (19)

Country Link
EP (1) EP1173426A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543193A (cg-RX-API-DMAC10.html)
KR (1) KR20010114250A (cg-RX-API-DMAC10.html)
CN (1) CN1145618C (cg-RX-API-DMAC10.html)
AU (1) AU766428B2 (cg-RX-API-DMAC10.html)
BG (1) BG106079A (cg-RX-API-DMAC10.html)
BR (1) BR0010213A (cg-RX-API-DMAC10.html)
CA (1) CA2371726A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20013951A3 (cg-RX-API-DMAC10.html)
EA (1) EA004512B1 (cg-RX-API-DMAC10.html)
HU (1) HUP0201609A3 (cg-RX-API-DMAC10.html)
IL (1) IL146280A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011286A (cg-RX-API-DMAC10.html)
NO (1) NO321361B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515355A (cg-RX-API-DMAC10.html)
PL (1) PL351127A1 (cg-RX-API-DMAC10.html)
SG (1) SG114650A1 (cg-RX-API-DMAC10.html)
SK (1) SK15912001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103286T2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
US20100160304A1 (en) * 2005-01-19 2010-06-24 Dainippon Sumitomo Pharma Co., Ltd Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2371726A1 (en) 2000-11-09
NZ515355A (en) 2004-02-27
AU4688600A (en) 2000-11-17
EA004512B1 (ru) 2004-04-29
SG114650A1 (en) 2005-09-28
PL351127A1 (en) 2003-03-24
EA200101176A1 (ru) 2002-04-25
TR200103286T2 (tr) 2002-07-22
NO20015378L (no) 2002-01-03
CZ20013951A3 (cs) 2002-05-15
CN1145618C (zh) 2004-04-14
BG106079A (en) 2002-05-31
SK15912001A3 (sk) 2002-06-04
NO20015378D0 (no) 2001-11-02
BR0010213A (pt) 2002-02-19
HUP0201609A2 (en) 2002-08-28
HUP0201609A3 (en) 2002-12-28
IL146280A0 (en) 2002-07-25
AU766428B2 (en) 2003-10-16
JP2002543193A (ja) 2002-12-17
CN1349517A (zh) 2002-05-15
EP1173426A1 (en) 2002-01-23
NO321361B1 (no) 2006-05-02
KR20010114250A (ko) 2001-12-31

Similar Documents

Publication Publication Date Title
ZA200108846B (en) Glucocorticoid receptor modulators.
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
MXPA01011070A (es) Derivados de esteroides.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
MXPA03003039A (es) Derivados de indola y bencimidazola como moduladores del receptor crf.
EP1170020A4 (en) EXTERNAL USE PADS
ZA200109595B (en) 13-methyl-erythromycin derivatives.
MXPA01011294A (es) Compuestos moduladores de receptor de progesterona tetraciclicos y metodos.
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL154984A0 (en) Estrogen receptor modulators
IL146151A0 (en) Human-g-protein receptor
HUP0203332A3 (en) Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
MXPA01012041A (es) Derivados de indol.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
AU5787201A (en) Compounds active at the glucocorticoid receptor
IL146280A0 (en) Cyclocarbamate derivatives as progesterone receptor modulators
MXPA01011285A (es) Derivados de tio-oxindol.
AU2574801A (en) Selective iGLUR5 receptor antagonists
GB9927215D0 (en) Hormone receptor expression
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
AU5545400A (en) Estrogen receptor
HK1043989A1 (zh) 作为黄体酮受体调节剂的环胺基甲酸盐衍生物
HK1043789A1 (zh) 作为黄体酮受体调节剂的环硫代胺基甲酸盐衍生物